Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
The active substance in, among others, Galanthamin, which can be extracted from snowdrops. It is already registred as a drug substance in Reminyl, used against dementia.
The research team has now recieved a EU grant of DKK 1,6 million to continue this research project and to, hopefully, find the base for new drugs in the future.
